Get startedLog in
    Picture of HLS Therapeutics logo

    HLS — HLS Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareBalancedSmall CapSuper Stock
    All News

    Brief: HLS Therapeutics Qtrly Loss Per Share $0.06

    Picture of HLS Therapeutics logoHLS Therapeutics
    07/11/2019 12:00
    Nov 7 (Reuters) - HLS Therapeutics Inc  HLS.TO :
    * HLS THERAPEUTICS ANNOUNCES Q3 2019 FINANCIAL RESULTS
    * QTRLY LOSS PER SHARE $0.06
    * Q3 REVENUE $13.4 MILLION VERSUS $15.3 MILLION

Source text for Eikon:  ID:nCNWMLLL2a 
Further company coverage:  HLS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on HLS Therapeutics

    See all news